On August 13, 2024, the US Food and Drug Administration (FDA) authorized nemolizumab for the treatment of adults with prurigo nodularis (PN).A first-in-class Read More
Tags :Nemolizumab
Recent Posts
- North Carolina Governor Vetoes Bill Blocking Federal CBDCs
- Tether CEO Paolo Ardoino Reveals How OpenAI Hack Could Have Been Prevented
- Ethereum (ETH) Price Is a Tad Bit Away From Triggering Accumulation
- Cardano (ADA) Price to Be Impacted by Opposing Opinions From Key Investor Cohort
- Germany Continues Significant Bitcoin Transfers, Moves $40 Million in BTC
Recent Comments
